Crescent Biopharma, Inc.
+123.2% · 90d
$25.15
+0.35 (+1.41%)
After-Hours $25.15(+0.00)
News
(1)April 2026
CBIO votes on board directors, auditors, and compensation at annual meeting
CBIOCRESCENT BIOPHARMA, INC.
# 🧾 What This Document Is 📜 This is a Proxy Statement (Schedule 14A), which is a critical legal filing used by companies to gather votes from their shareholders. It outlines the major business and governance decisions that shareholders are expected to vote on at the company’s Annual General Meetin
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%